Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder
- PMID: 37052904
- PMCID: PMC10102915
- DOI: 10.1001/jamaoncol.2023.0351
Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder
Erratum in
-
Errors in Table.JAMA Oncol. 2024 Aug 1;10(8):1138. doi: 10.1001/jamaoncol.2024.3130. JAMA Oncol. 2024. PMID: 38990547 Free PMC article. No abstract available.
Plain language summary
This nonrandomized controlled trial used a 1-to-1 therapist-to-patient ratio to administer psilocybin to groups of patients with cancer who were diagnosed with major depression disorder to create a scalable, rapidly effective depression treatment.
Conflict of interest statement
Similar articles
-
Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder.Cancer. 2024 Apr 1;130(7):1137-1146. doi: 10.1002/cncr.35010. Epub 2023 Dec 18. Cancer. 2024. PMID: 38105655 Clinical Trial.
-
Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer.Cancer. 2024 Apr 1;130(7):1028-1030. doi: 10.1002/cncr.35127. Epub 2023 Dec 18. Cancer. 2024. PMID: 38105654 No abstract available.
-
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.Can J Psychiatry. 2023 Jan;68(1):5-21. doi: 10.1177/07067437221111371. Epub 2022 Aug 17. Can J Psychiatry. 2023. PMID: 35975555 Free PMC article. Review.
-
HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.J Pain Symptom Manage. 2023 Sep;66(3):258-269. doi: 10.1016/j.jpainsymman.2023.06.006. Epub 2023 Jun 10. J Pain Symptom Manage. 2023. PMID: 37302533
-
Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.Psychiatry Res. 2023 Nov;329:115531. doi: 10.1016/j.psychres.2023.115531. Epub 2023 Oct 11. Psychiatry Res. 2023. PMID: 37844352 Review.
Cited by
-
Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey.Palliat Med. 2024 Feb;38(2):272-278. doi: 10.1177/02692163231222430. Epub 2024 Jan 22. Palliat Med. 2024. PMID: 38253521 Free PMC article.
-
Group psychedelic therapy: empirical estimates of cost-savings and improved access.Front Psychiatry. 2023 Dec 6;14:1293243. doi: 10.3389/fpsyt.2023.1293243. eCollection 2023. Front Psychiatry. 2023. PMID: 38125286 Free PMC article.
